Latest news
Oncologists Discuss Accelerated FDA Approvals and Surrogate Endpoints After Zepzelca Withdrawal - OncodailyOncodaily · Sun, 09 Aug 2026 16:07:14 GMTMannKind Corporation (MNKD) Discusses FDA Approval of Furoscix ReadyFlow for IV-Equivalent Diuretic Therapy in Fluid Overload - Slideshow (NASDAQ:MNKD) 2026-07-31 - Seeking AlphaSeeking Alpha · Fri, 31 Jul 2026 07:00:00 GMT